Judge Boosts Royalty Rate For Syntrix's Win in Patent Row
A Washington federal judge on Tuesday added to Syntrix Biosystems Inc.'s $115 million win in a suit alleging competitor Illumina Inc. infringed its patent covering DNA technology, finding the company was...To view the full article, register now.
Already a subscriber? Click here to view full article